Timonium, MD, United States of America

Douglas T Genna

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Douglas T Genna: Innovator in Antiproliferative Compounds

Introduction

Douglas T Genna is a notable inventor based in Timonium, MD (US). He has made significant contributions to the field of medicine through his innovative research and development of compounds that have the potential to treat diseases characterized by abnormal cell proliferation.

Latest Patents

Genna holds a patent for "Low calcemic, highly antiproliferative, analogs of calcitriol." This patent discloses compounds, compositions, and methods that utilize these compounds to stimulate the differentiation of cells and inhibit excessive cell proliferation. This is particularly relevant for certain cells, including cancer cells and skin cells. The compounds may be useful in treating diseases such as leukemia, myelofibrosis, and psoriasis, without the adverse effects on calcium metabolism that can lead to hypercalcemia.

Career Highlights

Douglas T Genna is affiliated with Johns Hopkins University, where he continues to advance his research in the field of cell differentiation and proliferation. His work is crucial in developing therapies that can effectively manage and treat various forms of cancer and other related conditions.

Collaborations

Genna has collaborated with esteemed colleagues, including Gary H Posner and Kimberly S Petersen, to further enhance the impact of his research and innovations.

Conclusion

Douglas T Genna's contributions to the field of medicine through his innovative patents and research at Johns Hopkins University highlight his commitment to improving treatment options for diseases characterized by abnormal cell proliferation. His work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…